4410 — Harima Chemicals Balance Sheet
0.000.00%
- ¥23bn
- ¥58bn
- ¥104bn
Annual balance sheet for Harima Chemicals, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6,631 | 6,301 | 6,851 | 4,746 | 6,264 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 20,042 | 22,210 | 21,703 | 20,696 | 20,563 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 44,238 | 49,791 | 53,588 | 52,143 | 53,371 |
| Net Property, Plant And Equipment | 23,402 | 27,118 | 28,498 | 32,383 | 33,783 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 78,905 | 92,439 | 98,583 | 100,044 | 102,886 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23,150 | 41,657 | 47,690 | 45,878 | 40,960 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 42,164 | 55,337 | 61,365 | 62,711 | 62,086 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 36,741 | 37,102 | 37,218 | 37,333 | 40,800 |
| Total Liabilities & Shareholders' Equity | 78,905 | 92,439 | 98,583 | 100,044 | 102,886 |
| Total Common Shares Outstanding |